Empagliflozin

Fecal microbiome predicts treatment response after the initiation of semaglutide or empagliflozin uptake

by

Skyler, J. S. et al. Differentiation of diabetes by pathophysiology, natural history, and prognosis. Diabetes 66, 241–255 (2016). Google Scholar  Li, G. et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing diabetes prevention study: a 23-year follow-up study. Lancet Diabetes Endocrinol. 2, … Read more

Dapagliflozin Comparable with Empagliflozin for Long-Term Kidney Outcomes in T2D

by

Patients with type 2 diabetes (T2D) exhibited similar outcomes when prescribed either empagliflozin or dapagliflozin for treating chronic kidney disease (CKD), according to data published in JAMA Internal Medicine.1 With study results showing neither drug is more effective than the other within this population, researchers agree with the current practice of not recommending either drug … Read more